Light activity like walking has no impact on medication absorption
Minor issues during injection are common, especially in the first few weeks
For individuals with type 2 diabetes, low blood sugar levels (hypoglycemia) can be a concern when GLP-1 agonists are used in combination with other glucose-lowering medications, such as sulfonylureas or insulin
The evidence base for GLP-1 receptor agonists in post-bariatric weight regain continues to expand, though large randomized controlled trials remain limited compared to primary obesity treatment
These cells are known as L-cells and are located mostly in the lower GI tract, such as the lower ileum and the colon
James Bradley, a renowned sports medicine surgeon and longtime professional team orthopedist, and Dr